This study examines the effectiveness of an intervention for minor depression in primary care patients. One hundred fifty public care medical patients were randomly assigned to either an 8-week cognitive-behavioral course intended to help them use pleasant activities, constructive thinking, and interpersonal relationships to improve mood or a control condition. Assessments were completed at postintervention, 6 months, and 1 year. The results support the effectiveness of the intervention. Persons with minor depression assigned to the intervention experienced reductions in depressive symptomatology, which persisted through the 1-year follow-up. In addition, the intervention lowered the somatic symptomatology that was associated with minor depression. Finally, those with minor depression who received the intervention missed fewer appointments with their primary care provider during the following year than did those with minor depression who received no intervention. The results from this preliminary evaluation suggest that interventions addressing minor depression in medical patients are feasible and are effective in reducing both depressive symptomatology and associated problems.
INTRODUCTION
This study examines the effectiveness of an intervention for minor depression in primary care patients. Although no uniform criteria for this disorder exist, several have been proposed, including the Research Diagnostic Criteria (RDC) (1) of depressed mood or anhedonia plus 1 or more additional depressive symptom of at least 2 weeks duration in a patient who does not meet criteria for a depressive disorder. Epidemiological studies evaluating minor depression in primary care patients using RDC criteria find prevalence ranging from 3.4 to 5.4% (2, 3, 4) , compared with 4% for Major Depressive Disorder. The prevalence of depression in disadvantaged, public sector patients is extraordinarily high. PerezStable, Miranda, Muiioz, and Ying (5) found that nearly 54% of English-speaking and 62% of Spanishspeaking patients reported significant rates of depressive symptomatology, with 26.4% of those who were depressed actually meeting criteria for major depression or dysthymia. Thus, minor depression is prevalent in medical patients, particularly in the public sector.
Significant impairment results from minor depression. Specifically, Wells et al. (6) found that medical patients with minor depression report decreased physical, social, and role functioning and report more sick days compared with patients without such symptoms. In fact, they found that the decrement in functioning in patients with minor depression is similar to that of patients with depressive disorder. In a similar study, Broadhead et al. (7) found higher rates of sick days in persons with minor depression as compared with those free of depressive symptoms. In addition to disability, subthreshold depressive symptoms in medical patients predict to a high incidence (25%) of major depression over a 2-year period (8j. Because minor depression is debilitating and frequently a precursor of major depression in primary care patients, interventions should be evaluated.
Somatization, the experience of psychological distress as physical, has frequently been linked with depressive symptomatology in medical patients. Katon and Russo (9) found that nearly 50% of depressed medical patients were somatizers (10) . Similarly, masked depression, a depression in which somatic symptoms are prominent, was found to be the most common depression (6.4%) in rural internal medicine practice patients (4) . An intervention that reduces minor depression may also decrease somatization in primary care patients.
Depression also affects medical service utilization. In the private sector, depressed patients have a greater frequency of clinic visits than their nondepressed counterparts (11) (12) (13) (14) . Similarly, general psychiatric distress results in increased use of general medical services, but significantly more so for nonHispanic whites than for Mexican Americans (15) . McHugh et al. (16) found that mental health treatment increased use of medical services among pub-lie care Mexican Americans, who generally underutilize services. Thus, an intervention that reduces minor depression may enable patients to utilize medical services more appropriately.
The present study evaluates the therapeutic efficacy of an intervention for minor depression in public sector medical patients. The data were gathered as part of a larger study to evaluate a cognitive behavioral intervention to prevent major depression in medical patients (17, 18) ; this is the first data available on the impact of such an intervention on minor depression in medical patients. The prevention trial excluded patients who met criteria for major depression, but allowed participation by primary care patients who had high depressive symptom levels as long as they did not cross the threshold into major depression or dysthymia.
The psychoeducational intervention was an 8-week cognitive-behavioral course (19] that was intended to teach patients to control negative moods. The course was similar to cognitive-behavioral therapy, a well-established short-term treatment for major depression in patients presenting to psychiatry (20, 21) . The course was not presented as therapy and, therefore, the primary care patients did not have to identify themselves as receiving psychiatric care.
In summary, this randomized study evaluates the impact of a group cognitive-behavioral intervention versus control on minor depression in medical patients. Impact of the intervention is evaluated for depressive symptomatology, somatic symptomatology, and medical utilization. We predict that the intervention will lower depressive and somatic symptomatology and increase appropriate medical utilization for patients with minor depression. In order to determine if the impact of the intervention is specific to depressive symptomatology, patients with minor depression are compared to those without minor depression.
A total of 708 patients completed a demographic questionnaire during a medical visit and were invited to return for an evaluation interview. Two hundred ninety-two returned for the evaluation, which consisted of the National Institute of Mental Health's Diagnostic Interview Schedule (DIS) (24). After this interview, 103 patients were excluded for meeting diagnostic criteria for major depression, dysthymia, substance abuse, or psychotic disorders; a small sample of 31 Cantonese or Mandarin-speaking patients were referred to a separate Chinese-language pilot study. Of those who met criteria for the randomized trial (N = 158), 150 (95%) agreed to be randomized.
The 150 subjects (93 women, 57 men) were randomly assigned to intervention (N = 72) or control (N = 78). They were ethnically diverse, with 23.7% African American, 10.1% Asian, 24.3% Latino, 35.1% Caucasian, and 6.8% other. Mean age was 52.5 years, mean annual income $11,500, and mean years of education 12.1. The majority (67.8%) were unemployed. Nearly 40% were married or living with a partner. 28% separated or divorced, 14.7% widowed, and 18% never married. There were no differences between the randomized groups in demographic characteristics, active medical problems, history of psychiatric disorder, or depressive symptoms.
These primary care patients had a mean of 3.8 active medical problems. The most common medical problems were as follows: 43% had hypertension, 21% heart disease, 22% diabetes mellitus, and 24% osteoarthritis. Patients were on an average of four medications; diuretics, beta blockers, and nonsteriodals were the most common. Patients attended an average of 4.9 clinic visits per year.
For the purposes of this study, subjects were further divided into those who met criteria for minor depression as indicated by significant depressive symptomatology in the absence of major depression or dysthymia. All patients with diagnosable major depression or dysthymia had previously been excluded. The Beck Depression Inventory (BDI) (25) . a 21-item measure of depressive symptomatology with scores ranging from 0 to 63, was used to ascertain presence of significant depressive symptomatology. BDI scores of 16 to 23 generally reflect moderate depression, and scores of 24 to 63 reflect severe depression (25) . Because medical patients have somatic symptoms that overlap with depressive symptoms, higher cut-off scores are advisable (26) . Subjects in this study were considered to have minor depression if their BDI scores were 18 or above, suggesting significant depressive symptomatology. Using this criterion, 49 (33%) of the patients had minor depression.
METHOD Subjects
Participants were recruited from primary care clinics at San Francisco General Hospital and the University of California, San Francisco Medical Center. Persons with clinic appointments during the previous 3 months were contacted either in person or by mail and were invited to participate in a study on mood and health. All subjects met these criteria: 1) provided informed consent, 2) were between 18 and 69 years of age, 3) were literate in English or Spanish, 4) were not currently receiving mental health treatment, 5) had a chart open for 6 months at the primary care clinic, and 6) agreed to participate for a 1-year period.
Measures
Symptoms of depression. The Beck Depression Inventory (25) described above served as a measure of depressive symptomatology.
Somatic symptomatology. Level of somatic symptoms was assessed using items from the somatization scale of the Hopkins Symptom Checklist (27) . Subjects indicated if they were currently experiencing a variety of symptoms such as heavy feelings in arms or legs, hot or cold spells, nausea, or upset stomach.
MedicaJ utilization. Medical record reviews were conducted for the 1-year period after administration of the DIS to determine number of visits to the outpatient ambulatory care clinics and number of missed visits.
Procedures
Screening lasted 2 to 4 weeks. At first contact, the study was described, the consent form signed, demographic information obtained, and a brief self-report depression measure administered. At the second meeting, the BDI and DIS were administered. At the third contact, a battery of questionnaires were completed in a 2-hour session. Participants were then informed about randomization into the study. Patients meeting criteria for major depression, dysthymia, or any other major disorder (schizophrenia, bipolar disorder, substance abuse, or organic brain syndrome) were excluded. Those who met inclusion criteria were randomly assigned to experimental or control condition. For all subjects, assessments occurred at 2 months (postintervention), 6 months, and 12 months. Participants received $10 for each evaluation session.
Intervention. The intervention conditions consisted of an 8-week, 2-hour per session course on cognitive behavioral methods to gain greater control of mood (the "Depression Prevention Course") (19). The instructors were doctoral level psychologists who followed a protocol in the form of a syllabus (Appendix) that included student outlines for each of the sessions, as well as instructor's notes. The syllabus was a simplified version of a social learning, self-control intervention for depression (28) . The techniques were adapted to a low-income, predominantly minority population by simplifying language and using culturally appropriate examples. A Spanish-language version was also prepared. The course was conducted in a small group format, with no more than ten persons per group.
The intervention covered the following topics: an introduction to depression, social learning theory, and self-control approaches (for example, learning to monitor daily mood level); analysis of how thoughts, activities, and interpersonal interactions affect mood; how to identify and change those thoughts, activities, and contacts with people that most affect each participant's mood level; how to determine if one's mood actually changes when one increases or decreases specific thoughts, behaviors, or interpersonal contacts; relaxation training; and how to plan one's life goals so that the probability that one will become depressed is as low as possible given one's circumstances.
Control. The control group was either a no-intervention condition or an information only condition of a 40-minute videotape. As there were no differences between the control groups, the two conditions are collapsed in all analyses.
Data analysis. The intervention effects were tested using intention to treat criterion (i.e., evaluating all subjects as randomized whether or not they attended treatment) and repeated measures analyses of variance, with time of testing (pre-, post-, 6-month, 1-year) as the repeated measure and intervention (treatment vs. control) and minor depression (present vs. absent) as between subjects factors.
RESULTS

Attrition
Twenty percent of those randomized to the intervention attended none of the eight sessions; 17% attended one to three sessions. Therefore, 62.5% attended at least half of the sessions.
There were no significant differences between completers and dropouts in demographic characteristics. Follow-up rates for assessment interviews were 92% at postintervention, 90% at 6 months, and 92% at 1 year. Follow-up rates for the experimental and control and depressed vs. nondepressed groups did not differ.
Intervention
We hypothesized that over time the intervention would decrease depressive symptomatology and somatization and increase appropriate medical utilization for those with minor depression but not for those who were asymptomatic. Repeated measures analysis of variance was used to evaluate the intervention by time by minor depression interaction.
Depressive symptomatology. The impact of the intervention on depressive symptomatology as measured by the BDI was evaluated. The repeated measures analysis of variance resulted in a significant intervention by minor depression by time interaction (F = 3.72, d/= 3, 342, p = .01). Results are presented in Figure 1 . As can be seen, for those with minor depression, the intervention resulted in a greater reduction in depression levels across time compared with those not treated. Persons with minor depression assigned to the intervention experienced reductions in depressive symptomatology that persisted through the 1-year follow-up.
Somatization. To determine if the intervention reduced somatization for those with minor depression, a repeated measures analysis of variance was conducted with the somatization scale from the Hopkins Symptom Checklist as the dependent measure. The analysis resulted in a significant intervention by minor depression by time interaction (F = 4.33, d/= 3, 345, p = .005). Results are presented in Figure 2 . As can be seen, for those with minor depression, somatization was significantly lower after treatment as compared with the control condition, and the somatic symptomatology remained low to the 1-year follow-up. The treatment did not lower somatization for the nondepressed groups. Thus, the intervention seems to have lowered somatic symptomatology associated with depression.
Medical utilization. In order to determine if the intervention was successful in helping patients with minor depression utilize medical services more appropriately, a series of analyses of variance were conducted with intervention (treatment vs. control) and minor depression (present vs. absent) as between subjects variables. Number of medical visits, missed appointments, and drop-in appointments the following year were dependent measures. There were no significant findings regarding number of medical visits or drop-in appointments. However, there was a significant intervention by minor depression interaction for missed visits (F = 4.5, df = 3, 137, p = 0.05). Means are presented in Table 1 .
As can be seen, the intervention resulted in fewer missed appointments for those with minor depression who received the intervention compared with those with minor depression who received no intervention.
DISCUSSION
The results from this preliminary evaluation of the efficacy of a cognitive-behavioral intervention for minor depression in primary care patients are encouraging. First, patients were generally willing to attend the cognitive behavioral intervention. Second, results suggest that the intervention was successful in reducing depressive symptomatology and somatization. In addition, those patients with minor depression who were treated missed fewer medical visits than those depressed patients who received no intervention. These results were specific to the sample with minor depression; those with initially low symptoms of depression neither decreased their somatic symptomatology nor increased appropriate medical utilization as a result of the intervention.
Given the significant functional impairment and high morbidity associated with minor depression, intervention seems warranted. These results document clear benefit from this cognitive-behavioral intervention. Future studies should specifically evaluate the impact of interventions for minor depression on functional impairment and subsequent major depression.
The impact of this treatment on somatization is equally important. Because somatization has been related to increased medical service utilization (29) (30) (31) (32) , psychiatric co-morbidity, alcoholism, and drug abuse (33) (34) (35) , intervention for these symptoms also seems warranted. Interestingly, these results suggest that the cognitive behavioral intervention was effective in treating the somatic symptomatology that was associated specifically with depression. The low-symptom sample who received the preventive intervention did not lower their general level of somatic symptomatology, which remained modestly high.
The intervention did lower the number of missed appointments for the subsyndromal patients the year after treatment. This is consistent with studies suggesting that disadvantaged, minority medical patients under-utilize medical services when depressed. Future studies are needed to determine if more advantaged patients will decrease overutilization of medical services in an intervention to address depressive symptomatology.
Although these preliminary findings with this small sample are encouraging, larger scale studies of interventions for minor depression are clearly needed. Because of the absence of an active control condition, treatment response cannot be attributed to the cognitive-behavioral approach, but may be due simply to attention given the participants. Future studies should consider evaluating other approaches, including those founded on social, economic, psychological, and biological factors. In addition, the differential acceptability of such interventions to medical patients should be evaluated. Finally, these studies should have extended follow-ups of at least 2 years to determine if intervention prevents onset of major depression.
